550 Participants Needed

Closed vs. Open Abdomen Management for Sepsis

AK
Overseen ByAndrew Kirkpatrick, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Calgary
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial compares two methods of managing the abdomen after surgery for severe abdominal infections. One method involves immediate closure of the abdomen (CLOSED, or Closed Abdomen Management), while the other keeps it open temporarily with a special dressing and vacuum drain (OPEN, or Open Abdomen Management with ANPPT dressing). The study aims to determine which approach is more effective for treating this serious condition. Individuals who have experienced a major abdominal infection with leakage into the abdomen during surgery and are in septic shock may be suitable candidates for this trial. As an unphased trial, it offers patients the chance to contribute to important research that could enhance treatment options for severe abdominal infections.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that these management techniques are safe for sepsis treatment?

Research shows that using an open abdomen management approach with a temporary abdominal closure (TAC) and negative pressure wound therapy (ANPPT) is generally safe, though risks exist. One study found that about 76.6% of patients successfully had their abdomen closed using this method. However, complications included a 7.2% chance of developing a fistula, an abnormal connection between organs, and 29.7% of patients experienced infection-related issues.

Other studies have shown that a vacuum-assisted closure system can achieve a high rate of successful abdominal closure, around 90%. However, patients with severe abdominal infections (abdominal sepsis) may face worse outcomes than those treated for injuries, with a higher chance of complications.

These findings suggest that while open abdomen management with ANPPT dressing is often effective, it carries some risk, especially in cases of severe infection.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it compares two different surgical techniques for managing sepsis, which is a life-threatening condition. The trial is evaluating whether keeping the abdomen closed with a drain or using an open abdomen approach with an ANPPT dressing is better. The open abdomen method uses a special dressing that applies negative pressure, which might help control infection and improve healing. This trial could provide valuable insights into which approach leads to better outcomes for patients with sepsis, potentially changing how this condition is managed in the future.

What evidence suggests that this trial's treatments could be effective for sepsis?

This trial will compare Closed Abdomen Management with Open Abdomen Management using an ANPPT dressing. Research has shown that a temporary abdominal closure (TAC) device, such as an ANPPT dressing, effectively treats severe abdominal infections. Studies have found that this method can increase the likelihood of successfully closing the abdominal wall later. It may also reduce death rates and shorten hospital stays for patients with severe abdominal infections. However, patients with abdominal infections might experience worse outcomes compared to those with injuries when using this method. Despite these challenges, incorporating negative pressure wound therapy (NPWT) into the TAC has effectively managed serious abdominal infections.14678

Who Is on the Research Team?

AW

Andrew W Kirkpatrick, MD

Principal Investigator

University of Calgary

Are You a Good Fit for This Trial?

This trial is for adults with severe abdominal sepsis, indicated by specific scores like the World-Society-of-Emergency-Surgery-Sepsis-Severity Score >8. It's not for pregnant individuals, those with high intra-abdominal pressure (IAP>20 mmHg), patients without plans for continued care, cases of pancreatitis-induced peritonitis, or uncontrolled bleeding.

Inclusion Criteria

I am currently experiencing septic shock.
World-Society-of-Emergency-Surgery-Sepsis-Severity-Score > 8
Predisposition-Infection-Response-Organ Dysfunction Score > 3
See 1 more

Exclusion Criteria

My peritonitis is caused by pancreatitis.
I do not have any ongoing issues with uncontrolled bleeding.
I do not plan to continue receiving treatment.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants undergo either closed or open abdomen management with ANPPT dressing after laparotomy for severe intra-abdominal infection

24-72 hours
Intra-operative randomization and initial post-operative care

Follow-up

Participants are monitored for survival, blood IL-6 levels, and ICU stay duration

90 days
Regular follow-up visits and monitoring

Post-operative Care

Formal abdominal closure or dressing change at 24-72 hours from placement

1-3 days

What Are the Treatments Tested in This Trial?

Interventions

  • Closed Abdomen Management
  • Open Abdomen Management with ANPPT dressing
Trial Overview The study compares two methods to manage abdominal infections after surgery: 'Closed Abdomen Management' where the surgical cut is closed right away and 'Open Abdomen Management' where it's left open with a vacuum dressing applied. Participants are randomly assigned to one of these treatments.
How Is the Trial Designed?
2Treatment groups
Active Control
Placebo Group
Group I: Open Abdomen Management with ANPPT dressingActive Control1 Intervention
Group II: Closed Abdomen ManagementPlacebo Group1 Intervention

Closed Abdomen Management is already approved in European Union, United States for the following indications:

🇪🇺
Approved in European Union as Primary Fascial Closure for:
🇺🇸
Approved in United States as Primary Fascial Closure for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Calgary

Lead Sponsor

Trials
827
Recruited
902,000+

Alberta Health services

Collaborator

Trials
168
Recruited
658,000+

Published Research Related to This Trial

The artificial burr technique and vacuum-assisted closure (VAC) method are associated with the highest rates of delayed primary fascial closure (90% and 60%, respectively) in patients with an open abdomen due to trauma or infection.
Both the artificial burr and VAC techniques also demonstrate lower mortality rates (17% and 18%, respectively), indicating they are not only effective but also safer options for temporary abdominal closure.
Temporary closure of the open abdomen: a systematic review on delayed primary fascial closure in patients with an open abdomen.Boele van Hensbroek, P., Wind, J., Dijkgraaf, MG., et al.[2022]
A study comparing 77 trauma patients and 147 septic patients undergoing temporary abdominal closure (TAC) revealed that trauma patients had higher rates of hypothermia, severe acidosis, and coagulopathy, while septic patients required more vasopressor support, indicating different resuscitation needs for each group.
Among patients who survived to discharge, trauma patients had a higher primary fascial closure (PFC) rate of 90% compared to 76% for septic patients, suggesting that the underlying conditions significantly affect surgical outcomes and closure success.
Temporary abdominal closure for trauma and intra-abdominal sepsis: Different patients, different outcomes.Loftus, TJ., Jordan, JR., Croft, CA., et al.[2018]
In a study of 355 adult patients treated with the open abdomen technique, those who achieved fascial closure had a higher initial rate of open abdomen procedures and shorter times to subsequent operations, indicating that early intervention may improve closure outcomes.
The presence of pancreatitis was identified as a negative prognostic factor for achieving fascial closure, while factors like the timing of operations and initial treatment method positively influenced closure success.
Fascial closure after open abdomen: initial indication and early revisions are decisive factors--a retrospective cohort study.Lambertz, A., Mihatsch, C., Röth, A., et al.[2022]

Citations

Retrospective Study of Indications and Outcomes of Open ...Abdominal closure with negative pressure wound therapy (NPWT) has shown rates of DFC around 90%. We conducted a retrospective study to evaluate ...
Narrative Review of Open Abdomen Management and ...The consequences of not closing an abdomen in a timely manner can lead to frozen or hostile abdomens as well as other complications such as ...
Management of the open abdomen using negative ...NPWT-I in patients with severe abdominal sepsis had promising results, since we obtained higher fascia closure rates, lower mortality and reduced hospital and ...
The role of the open abdomen procedure in managing severe ...Compared with trauma patients, patients with abdominal sepsis have been described to have worse outcomes after OA, with increased incidence of ...
Narrative Review of Open Abdomen Management and ...The ideal temporary abdominal closure technique (TAC) should be easy to use, require limited dressing changes, prevent abdominal fascia ...
Open abdomen management: A review of its history and ...They achieved fascial closure rates of 76.6% in intention-to-treat analysis and 89% in per-protocol analysis. They had a 7.2% fistula rate and a 29.7% in- ...
Retrospective Study of Indications and Outcomes of Open ...Abdominal closure with negative pressure wound therapy (NPWT) has shown rates of DFC around 90%. We conducted a retrospective study to evaluate ...
Open Abdomen Management, A Review: Part 2Treatment of the open abdomen with the commercially available vacuum-assisted closure system in patients with abdominal sepsis: low primary closure rate.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security